MFIMFI
SUPN icon

Mesirow Financial Investment Management - Fixed Income’s Supernus Pharmaceuticals SUPN Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-398,885
Closed -$11.5M – 93
2022
Q2 		$11.5M Buy
398,885
+19,010
+5% +$544K 1.48% 14
2022
Q1 		$12.3M Sell
379,875
-100
-0% -$3.07K 1.36% 22
2021
Q4 		$11.1M Buy
379,975
+48,835
+15% +$1.48M 1.22% 22
2021
Q3 		$8.83M Buy
+331,140
New +$8.89M 1.02% 43
2019
Q2 		– Sell
-163,691
Closed -$5.74M – 132
2019
Q1 		$5.74M Buy
163,691
+46,805
+40% +$1.74M 0.89% 65
2018
Q4 		$3.88M Sell
116,886
-127,470
-52% -$5.48M 0.52% 74
2018
Q3 		$12.3M Sell
244,356
-12,045
-5% -$595K 1.12% 49
2018
Q2 		$15.3M Sell
256,401
-25,655
-9% -$1.33M 1.41% 18
2018
Q1 		$12.9M Sell
282,056
-95,405
-25% -$3.98M 1.27% 40
2017
Q4 		$15M Buy
377,461
+22,506
+6% +$889K 1.06% 66
2017
Q3 		$14.2M Buy
354,955
+142,215
+67% +$6.15M 0.94% 74
2017
Q2 		$9.17M Buy
+212,740
New +$7.57M 0.61% 74

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's SUPN Position: Q3 2022 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Supernus Pharmaceuticals (SUPN) in Q3 2022, closing a stake of 398,885 shares — an estimated $11.5M sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in SUPN in Q2 2017 and held it in 12 quarters. The position peaked at $15.3M in Q2 2018. 244 funds tracked by Wall St. Rank hold SUPN as of Q3 2022.

  • Mesirow Financial Investment Management - Fixed Income reported no remaining Supernus Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Mesirow Financial Investment Management - Fixed Income sold 398,885 Supernus Pharmaceuticals shares in Q3 2022, an estimated $11.5M.
  • Mesirow Financial Investment Management - Fixed Income first reported a position in Supernus Pharmaceuticals in Q2 2017 and held it in 12 quarters.
  • Mesirow Financial Investment Management - Fixed Income's Supernus Pharmaceuticals position peaked at $15.3M in Q2 2018.
  • 244 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2022.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q3 2022, filed 8 Nov 2022.